Turpentine Ointment in Bacterial Skin Infections: A Randomized, Placebo-Controlled, Double-Blind Clinical Trial

Background: Turpentine-containing substances are considered effective in treating cutaneous bacterial infections, but reliable clinical data are scant. Objective: We investigated the efficacy and safety of an ointment containing larch turpentine (from Larix decidua), eucalyptus oil (from Eucalyptus globulus), and turpentine oil (from Pinus pinaster) in outpatients with painful skin abscesses in a randomized, placebo-controlled, double-blind study. Intervention: 116 outpatients with skin abscesses used verum or placebo for 10 days. Sum score of the patient’s discomforts, changes in abscess size, rate of therapeutic success, and complete healing served as outcome parameters. Results: Fifty-four patients were treated with verum and 56 with placebo. According to the patient’s discomfort sum score, patients in the verum group showed a better improvement compared to the placebo group (7.3 vs. 4.7; p = 0.024), and subjective assessment by the investigators revealed a higher treatment success rate after verum (70% vs. 48%; p = 0.021). Complete healing was documented in 67% of the patients receiving verum versus 46% in the placebo group (p = 0.037). There was a positive trend toward a larger decrease in the abscess sizes in the verum group compared to the placebo group (p = 0.07). Conclusion: The ointment studied is an effective and safe option for the treatment of bacterial skin diseases.

[1]  E. Coccia,et al.  Worldwide Epidemiology and Antibiotic Resistance of Staphylococcus aureus. , 2016, Current topics in microbiology and immunology.

[2]  Anne M Johnson,et al.  Incidence and recurrence of boils and abscesses within the first year: a cohort study in UK primary care. , 2015, The British journal of general practice : the journal of the Royal College of General Practitioners.

[3]  E. P. Dellinger,et al.  Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America , 2014 .

[4]  C. Kromann,et al.  Recurrent furunculosis – challenges and management: a review , 2014, Clinical, cosmetic and investigational dermatology.

[5]  G. Doern,et al.  Antimicrobial Stewardship Programs , 2013, Journal of Clinical Microbiology.

[6]  D. Talan,et al.  Acute bacterial skin infections: developments since the 2005 Infectious Diseases Society of America (IDSA) guidelines. , 2013, The Journal of emergency medicine.

[7]  J. Suaya,et al.  Incidence, microbiology, and patient characteristics of skin and soft-tissue infections in a U.S. population: a retrospective population-based study , 2013, BMC Infectious Diseases.

[8]  L. Miller,et al.  Innate and adaptive immune responses against Staphylococcus aureus skin infections , 2012, Seminars in Immunopathology.

[9]  U. Jappe,et al.  Diagnosis and treatment of Staphylococcus aureus infections of the skin and mucous membranes , 2011, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[10]  M. Dryden Skin and soft tissue infection: microbiology and epidemiology. , 2009, International journal of antimicrobial agents.

[11]  J. Molnár,et al.  Antimicrobial and antiplasmid activities of essential oils. , 2006, Fitoterapia.

[12]  T. Takahashi,et al.  Antimicrobial activities of eucalyptus leaf extracts and flavonoids from Eucalyptus maculata , 2004, Letters in applied microbiology.

[13]  J. Damas,et al.  The mechanism of the anti-inflammatory effect of turpentine in the rat , 1984, Naunyn-Schmiedeberg's Archives of Pharmacology.

[14]  M. Prost,et al.  The essential oil of turpentine and its major volatile fraction (alpha- and beta-pinenes): a review. , 2009, International journal of occupational medicine and environmental health.

[15]  J. Glamočlija,et al.  SUSCEPTIBILITY OF THREE CLINICAL ISOLATES OF ACTINOMODURA MADURAE TO α-PINENE, THE BIOACTIVE AGENT OF PINUS PINASTER TURPENTINE OIL , 2008 .